Topic: Cipla

An Indian company, Cipla, is reportedly preparing to flood the market with generic Tamiflu, which may explain Roche's urgency in selling existing stock. The hosts discuss the complexities of pharmaceutical patents and the practice of drug companies marketing against generic alternatives as the patent expiration date approaches.